首页> 外文OA文献 >PCV42 Comparison of Dabigatran Etexilate Versus Warfarin, Asprin No Treatment for Stroke Prevention in Atrial Fibrillation in England, United Kingdom, Over 5 Years

【2h】

PCV42 Comparison of Dabigatran Etexilate Versus Warfarin, Asprin No Treatment for Stroke Prevention in Atrial Fibrillation in England, United Kingdom, Over 5 Years

机译：达比加群酯与华法林，阿司匹林和未经治疗预防房颤的卒中的PCV42对比，英国，英国，超过5年

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sunderland T.J.; Zah V.; McCarron C.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate. [J] . Roskell NS, Lip GY, Noack H, Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2010,第6期

机译：心房颤动中风预防的治疗：网络荟萃分析和达比加群酯的间接比较。
2. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation [J] . AmorosiS.L., ArmstrongS., DaDeppoL., Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . 2014,第8期

机译：与调整剂量的华法令和达比加群依替尼酯相比，左心耳封堵对房颤预防中风的预防作用
3. Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis" [J] . Machado-Alba Jorge Enrique, Arias-Jaramillo Daniel Ricardo, Gaviria-Mendoza Andres Stroke: A Journal of Cerebral Circulation . 2017,第6期

机译：Machado-Alba等人关于文章的信，“Rivaroxaban对Dabigatran或Warfarin在真实颤动中的卒中预防研究中的实际研究：系统评价和Meta-Analysis”
4. Comparison of Engineering Education in the United States versus the United Kingdom [C] . Pete Hylton, Wendy Otoupal-Hylton American Society for Engineering Education Annual Conference and Exposition . 2017

机译：与英国的工程教育比较与英国
5. Dabigatran versus warfarin for the prevention of stroke in patients with chronic nonvalvular atrial fibrillation. [D] . Qiu, Fen. 2011

机译：达比加群与华法林预防慢性非瓣膜性房颤患者的中风。
6. Treatment Persistence and Discontinuation with Rivaroxaban Dabigatran and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States [O] . Craig I. Coleman, Muralikrishna Tangirala, Thomas Evers -1

机译：在美国非瓣膜性心房颤动患者中使用利伐沙班达比加群和华法林的治疗持久性和停药预防卒中。
7. PCV43 Comparison of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Atrial Fibrillation in Ireland Over 5 Years [O] . McCarron C., Sunderland T.J., Zah V. 2013

机译：达比加群酯与华法林对爱尔兰心房颤动预防卒中的5年比较

PCV42 Comparison of Dabigatran Etexilate Versus Warfarin, Asprin No Treatment for Stroke Prevention in Atrial Fibrillation in England, United Kingdom, Over 5 Years

著录项

引文网络

相似文献

相关主题

期刊订阅